Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remuzzi

Showing results (161-170 of 546) with videos related to

Pageof 55
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 1, 2010
Optimizing allocation of kidneys from older donorsP Ruggenenti, P Cravedi, G Remuzzi
Kidney International. Supplement|November 14, 1997
Role of increased glomerular protein traffic in the progression of renal failureI Bruzzi, A Benigni, G Remuzzi
Drug Safety|July 11, 2001
Drug-induced thrombotic microangiopathy: incidence, prevention and managementR Pisoni, P Ruggenenti, G Remuzzi
Kidney International. Supplement|March 1, 1997
Pathogenesis and treatment of thrombotic microangiopathyP Ruggenenti, J Lutz, G Remuzzi
Contributions to Nephrology|January 1, 1996
Proteins abnormally filtered throughout glomerular capillary have an intrinsic renal toxicityG Remuzzi, A Perna, A Benigni
Drugs of Today (Barcelona, Spain : 1998)|January 27, 2004
Pharmacological and clinical profile of valsartanA Remuzzi, N Perico, G Remuzzi
Transplantation Proceedings|September 2, 1998
Optimization of cyclosporine therapy in kidney transplantationG Remuzzi, N Perico, F Gaspari
Rivista Dell'Infermiere|January 1, 1992
[Transplants]G Remuzzi, N Perico, P Ruggenenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Low-dose rituximab for posttransplant recurrent membranous nephropathyP Cravedi, P Ruggenenti, G Remuzzi
Mineral and Electrolyte Metabolism|January 1, 1997
Nitric oxide synthesis and L-arginine in uremiaS Aiello, M Noris, G Remuzzi
Pageof 55

Showing results (161-170 of 546) with videos related to

Sort By:
Pageof 55
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 1, 2010
Optimizing allocation of kidneys from older donorsP Ruggenenti, P Cravedi, G Remuzzi
Kidney International. Supplement|November 14, 1997
Role of increased glomerular protein traffic in the progression of renal failureI Bruzzi, A Benigni, G Remuzzi
Drug Safety|July 11, 2001
Drug-induced thrombotic microangiopathy: incidence, prevention and managementR Pisoni, P Ruggenenti, G Remuzzi
Kidney International. Supplement|March 1, 1997
Pathogenesis and treatment of thrombotic microangiopathyP Ruggenenti, J Lutz, G Remuzzi
Contributions to Nephrology|January 1, 1996
Proteins abnormally filtered throughout glomerular capillary have an intrinsic renal toxicityG Remuzzi, A Perna, A Benigni
Drugs of Today (Barcelona, Spain : 1998)|January 27, 2004
Pharmacological and clinical profile of valsartanA Remuzzi, N Perico, G Remuzzi
Transplantation Proceedings|September 2, 1998
Optimization of cyclosporine therapy in kidney transplantationG Remuzzi, N Perico, F Gaspari
Rivista Dell'Infermiere|January 1, 1992
[Transplants]G Remuzzi, N Perico, P Ruggenenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Low-dose rituximab for posttransplant recurrent membranous nephropathyP Cravedi, P Ruggenenti, G Remuzzi
Mineral and Electrolyte Metabolism|January 1, 1997
Nitric oxide synthesis and L-arginine in uremiaS Aiello, M Noris, G Remuzzi
Pageof 55